BINEX Co., Ltd. (KOSDAQ:053030)
15,190
+460 (3.12%)
Apr 1, 2025, 3:30 PM KST
BINEX Revenue
In the year 2024, BINEX had annual revenue of 130.05B KRW, down -16.00%. BINEX had revenue of 35.96B in the quarter ending December 31, 2024, with 1.23% growth.
Revenue
130.05B
Revenue Growth
-16.00%
P/S Ratio
3.64
Revenue / Employee
223.45M
Employees
582
Market Cap
483.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 130.05B | -24.77B | -16.00% |
Dec 31, 2023 | 154.82B | -1.85B | -1.18% |
Dec 31, 2022 | 156.68B | 22.28B | 16.58% |
Dec 31, 2021 | 134.40B | 1.42B | 1.07% |
Dec 31, 2020 | 132.98B | 7.72B | 6.16% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |